Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_assertion type Assertion NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_head.
- NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_assertion description "[During active disease, patients with granulomatosis with polyangiitis (GPA; Wegener's granulomatosis) have accelerated atherosclerosis and ANGII inhibitors are recommended to these patients to reduce atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_provenance.
- NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_assertion evidence source_evidence_literature NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_provenance.
- NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_assertion SIO_000772 21936613 NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_provenance.
- NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_assertion wasDerivedFrom befree-20150227 NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_provenance.
- NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_assertion wasGeneratedBy ECO_0000203 NP228908.RAeV9RD-Gi1JfVND_2ZdBvuwByc-rf61Bz-DQVga5uQMA130_provenance.